Frank A. Bucci
About
In The Last Decade
Frank A. Bucci
34 papers receiving 453 citations
Peers
Comparison fields: 5 of 64
- Ophthalmology 323
- Public Health, Environmental and Occupational Health 175
- Radiology, Nuclear Medicine and Imaging 132
- Pharmacology 92
- Physiology 73
Countries citing papers authored by Frank A. Bucci
This map shows the geographic impact of Frank A. Bucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank A. Bucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank A. Bucci more than expected).
Fields of papers citing papers by Frank A. Bucci
This network shows the impact of papers produced by Frank A. Bucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank A. Bucci. The network helps show where Frank A. Bucci may publish in the future.
Co-authorship network of co-authors of Frank A. Bucci
This figure shows the co-authorship network connecting the top 25 collaborators of Frank A. Bucci. A scholar is included among the top collaborators of Frank A. Bucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank A. Bucci. Frank A. Bucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 29 | |
| 3 | 13 | |
| 4 | 4 | |
| 5 | Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.45%, Bromfenac 0.09%, and Nepafenac 0.1% in Patients Undergoing Phacoemulsification | 3 |
| 6 | 18 | |
| 7 | Aqueous Penetration of Ketorolac 0.4% Compared With Bromfenac 0.09% in Cataract Patients: Peak and Trough Drug Concentrations | 2 |
| 8 | Bilateral Multifocal Cataract and Lensectomy Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR - Long Term Follow-Up | 2 |
| 9 | 32 | |
| 10 | 20 | |
| 11 | Efficacy of Ketorolac 0.5% versus Ketorolac 0.4% Following Cataract Surgery | 1 |
| 12 | Comparison of Ketorolac 0.5%, Ketorolac 0.4%, and Diclofenac 0.1% – Combined With Prednisolone 0.1% on Aqueous Flare Following Cataract Surgery | 4 |
| 13 | The Effect of Preop Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior to Cataract Surgery | 5 |
| 14 | 1 | |
| 15 | 4 | |
| 16 | 2 | |
| 17 | 7 | |
| 18 | 7 | |
| 19 | 8 | |
| 20 | 20 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.